#METABOLOMICS WORKBENCH juliehaines_20211122_120944 DATATRACK_ID:2939 STUDY_ID:ST001998 ANALYSIS_ID:AN003260 PROJECT_ID:000000
VERSION             	1
CREATED_ON             	November 22, 2021, 12:25 pm
#PROJECT
PR:PROJECT_TITLE                 	Polyamine import and accumulation causes immunomodulation in macrophages
PR:PROJECT_TITLE                 	engulfing apoptotic cells
PR:PROJECT_SUMMARY               	Phagocytosis of apoptotic cells, termed efferocytosis, is critical for tissue
PR:PROJECT_SUMMARY               	homeostasis and drives anti-inflammatory programming in engulfing macrophages.
PR:PROJECT_SUMMARY               	Here, we assess metabolites in naïve and inflammatory macrophages following
PR:PROJECT_SUMMARY               	engulfment of multiple cellular and non-cellular targets. Efferocytosis leads to
PR:PROJECT_SUMMARY               	unique increases in the arginine-derived polyamines, spermidine and spermine, in
PR:PROJECT_SUMMARY               	vitro and in vivo. Surprisingly, polyamine accumulation after efferocytosis does
PR:PROJECT_SUMMARY               	not arise from retention of apoptotic cell metabolites or de novo synthesis, but
PR:PROJECT_SUMMARY               	from enhanced polyamine import that is dependent on Rac1, actin, and PI3 kinase.
PR:PROJECT_SUMMARY               	Blocking polyamine import prevents efferocytosis from suppressing macrophage
PR:PROJECT_SUMMARY               	IL-1beta or IL-6. This identifies efferocytosis as a trigger for polyamine
PR:PROJECT_SUMMARY               	import and accumulation, and imported polyamines as mediators of
PR:PROJECT_SUMMARY               	efferocytosis-induced immune reprogramming.
PR:INSTITUTE                     	University of Colorado Denver
PR:LAST_NAME                     	Haines
PR:FIRST_NAME                    	Julie
PR:ADDRESS                       	12801 E 17th Ave, Room 1303, Aurora, Colorado, 80045, USA
PR:EMAIL                         	julie.haines@cuanschutz.edu
PR:PHONE                         	3037243339
#STUDY
ST:STUDY_TITLE                   	Polyamine import and accumulation causes immunomodulation in macrophages
ST:STUDY_TITLE                   	engulfing apoptotic cells (Part 3)
ST:STUDY_SUMMARY                 	Phagocytosis of apoptotic cells, termed efferocytosis, is critical for tissue
ST:STUDY_SUMMARY                 	homeostasis and drives anti-inflammatory programming in engulfing macrophages.
ST:STUDY_SUMMARY                 	Here, we assess metabolites in naïve and inflammatory macrophages following
ST:STUDY_SUMMARY                 	engulfment of multiple cellular and non-cellular targets. Efferocytosis leads to
ST:STUDY_SUMMARY                 	unique increases in the arginine-derived polyamines, spermidine and spermine, in
ST:STUDY_SUMMARY                 	vitro and in vivo. Surprisingly, polyamine accumulation after efferocytosis does
ST:STUDY_SUMMARY                 	not arise from retention of apoptotic cell metabolites or de novo synthesis, but
ST:STUDY_SUMMARY                 	from enhanced polyamine import that is dependent on Rac1, actin, and PI3 kinase.
ST:STUDY_SUMMARY                 	Blocking polyamine import prevents efferocytosis from suppressing macrophage
ST:STUDY_SUMMARY                 	IL-1beta or IL-6. This identifies efferocytosis as a trigger for polyamine
ST:STUDY_SUMMARY                 	import and accumulation, and imported polyamines as mediators of
ST:STUDY_SUMMARY                 	efferocytosis-induced immune reprogramming.
ST:INSTITUTE                     	University of Colorado Denver
ST:LAST_NAME                     	Haines
ST:FIRST_NAME                    	Julie
ST:ADDRESS                       	12801 E 17th Ave, Room 1303, Aurora, Colorado, 80045, USA
ST:EMAIL                         	julie.haines@cuanschutz.edu
ST:PHONE                         	3037243339
#SUBJECT
SU:SUBJECT_TYPE                  	Cultured cells
SU:SUBJECT_SPECIES               	Mus musculus
SU:TAXONOMY_ID                   	10090
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	unexp1	category:unexposed macrophages	RAW_FILE_NAME=14
SUBJECT_SAMPLE_FACTORS           	-	unexp2	category:unexposed macrophages	RAW_FILE_NAME=17
SUBJECT_SAMPLE_FACTORS           	-	unexp3	category:unexposed macrophages	RAW_FILE_NAME=20
SUBJECT_SAMPLE_FACTORS           	-	1 -	category:non-engulfing	RAW_FILE_NAME=15
SUBJECT_SAMPLE_FACTORS           	-	2 -	category:non-engulfing	RAW_FILE_NAME=18
SUBJECT_SAMPLE_FACTORS           	-	3 -	category:non-engulfing	RAW_FILE_NAME=21
SUBJECT_SAMPLE_FACTORS           	-	1 +	category:engulfing	RAW_FILE_NAME=16
SUBJECT_SAMPLE_FACTORS           	-	2 +	category:engulfing	RAW_FILE_NAME=19
SUBJECT_SAMPLE_FACTORS           	-	3 +	category:engulfing	RAW_FILE_NAME=22
#COLLECTION
CO:COLLECTION_SUMMARY            	LPS-primed murine peritoneal macrophages were fed fluorescently-tagged apoptotic
CO:COLLECTION_SUMMARY            	Jurkat cells for 1h. Unengulfed targets were washed off and macrophages were
CO:COLLECTION_SUMMARY            	left to degrade targets for a further 3 hours. Macrophages were then collected
CO:COLLECTION_SUMMARY            	and sorted into non-engulfing or engulfing populations, alongside control
CO:COLLECTION_SUMMARY            	unexposed macrophages. Sorted cells were pelleted at 400xg and dry pellets were
CO:COLLECTION_SUMMARY            	snap frozen and stored at -80C until metabolite extraction.
CO:SAMPLE_TYPE                   	Macrophages
#TREATMENT
TR:TREATMENT_SUMMARY             	LPS-primed murine peritoneal macrophages were fed fluorescently-tagged apoptotic
TR:TREATMENT_SUMMARY             	Jurkat cells for 1h. Unengulfed targets were washed off and macrophages were
TR:TREATMENT_SUMMARY             	left to degrade targets for a further 3 hours. Macrophages were then collected
TR:TREATMENT_SUMMARY             	and sorted into non-engulfing or engulfing populations, alongside control
TR:TREATMENT_SUMMARY             	unexposed macrophages. Sorted cells were pelleted at 400xg and dry pellets were
TR:TREATMENT_SUMMARY             	snap frozen and stored at -80C until metabolite extraction.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	To process cells for assessment of intracellular metabolites, cells were
SP:SAMPLEPREP_SUMMARY            	pelleted at 400xg in tubes coated with 0.06% BSA. Supernatant was aspirated and
SP:SAMPLEPREP_SUMMARY            	discarded; residual liquid was carefully wicked away from the pellet with a
SP:SAMPLEPREP_SUMMARY            	kimwipe. Dry pellets were immediately snap frozen and stored at -80C until
SP:SAMPLEPREP_SUMMARY            	processing. To process culture supernatants for assessment of metabolites,
SP:SAMPLEPREP_SUMMARY            	supernatant was centrifuged at 400xg to pellet any cells. Cell-free supernatant
SP:SAMPLEPREP_SUMMARY            	was then transferred to a fresh tube, snap frozen, and stored at -80C until
SP:SAMPLEPREP_SUMMARY            	processing. Ultra-high pressure liquid chromatography-mass spectrometry
SP:SAMPLEPREP_SUMMARY            	(UHPLC-MS) was performed by the University of Colorado School of Medicine
SP:SAMPLEPREP_SUMMARY            	Metabolomics Core. Metabolites from frozen cell pellets were extracted at 2e6
SP:SAMPLEPREP_SUMMARY            	cells/mL in ice cold 5:3:2 MeOH:acetonitrile:water (v/v/v). Media was thawed on
SP:SAMPLEPREP_SUMMARY            	ice and a 10 L aliquot treated with 240 L of the same extraction solution.
SP:SAMPLEPREP_SUMMARY            	Extractions were carried out using vigorous vortexing for 30 min at 4C.
SP:SAMPLEPREP_SUMMARY            	Supernatants were clarified by centrifugation (10 min, 18,000 g, 4C) and
SP:SAMPLEPREP_SUMMARY            	analyzed using a Thermo Vanquish UHPLC coupled to a Thermo Q Exactive mass
SP:SAMPLEPREP_SUMMARY            	spectrometer.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	Isocratic flow of 250 uL/min of 100% A (95% water, 5% acetonitrile, 10 mM
CH:CHROMATOGRAPHY_SUMMARY        	ammonium acetate).
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Thermo Vanquish
CH:COLUMN_NAME                   	Phenomenex Kinetex C18 (150 x 2.1mm, 2.6 um)
CH:FLOW_GRADIENT                 	isocratic
CH:FLOW_RATE                     	250 ul/min
CH:COLUMN_TEMPERATURE            	25
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo Q Exactive Orbitrap
MS:INSTRUMENT_TYPE               	Orbitrap
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	Global metabolomics analyses were performed using a 3 min isocratic run in
MS:MS_COMMENTS                   	positive and negative ion modes (separate runs) as described previously (Nemkov
MS:MS_COMMENTS                   	et al., 2015, Nemkov et al., 2017); stable isotope tracing samples were analyzed
MS:MS_COMMENTS                   	using a 5 min C18 gradient in positive and negative ion modes (separate runs) as
MS:MS_COMMENTS                   	described (Nemkov et al., 2019, Gehrke et al., 2019). For all analyses, the MS
MS:MS_COMMENTS                   	scanned in MS1 mode across the m/z range of 65 to 950. Peaks were annotated (in
MS:MS_COMMENTS                   	conjunction with the KEGG database), integrated, and quality control performed
MS:MS_COMMENTS                   	using Maven (Princeton University) as described. Stable isotope tracing results
MS:MS_COMMENTS                   	were isotopically corrected for the natural abundance of 13C1, 13C2, 15N1, and
MS:MS_COMMENTS                   	15N2 (Nemkov et al., 2017).
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	peak area
MS_METABOLITE_DATA_START
Samples	unexp1	unexp2	unexp3	1 -	2 -	3 -	1 +	2 +	3 +
Factors	category:unexposed macrophages	category:unexposed macrophages	category:unexposed macrophages	category:non-engulfing	category:non-engulfing	category:non-engulfing	category:engulfing	category:engulfing	category:engulfing
ADP	9.21E+03	8.93E+03	1.10E+04	1.50E+04	1.13E+04	1.13E+04	8.34E+03	1.09E+04	1.09E+04
Urate	1.31E+05	9.30E+04	1.16E+05	1.06E+05	1.15E+05	1.40E+05	2.19E+05	3.77E+05	2.28E+05
3',5'-Cyclic IMP	1.87E+04	2.98E+03	3.64E+04	2.42E+05	0.00E+00	5.03E+04	3.69E+05	0.00E+00	1.57E+04
Phosphate	7.74E+07	7.11E+07	7.07E+07	9.18E+07	7.59E+07	8.05E+07	7.49E+07	6.39E+07	6.14E+07
Diphosphate	9.41E+06	6.75E+06	7.42E+06	9.35E+06	1.04E+07	7.42E+06	5.89E+06	7.52E+06	5.11E+06
D-Glucose	3.20E+06	3.43E+06	3.12E+06	4.64E+06	1.32E+06	3.88E+06	5.99E+06	1.62E+06	3.72E+06
D-Glucose 6-phosphate	4.16E+05	3.19E+05	3.54E+05	5.80E+05	3.33E+05	4.96E+05	5.73E+05	5.99E+05	6.14E+05
Pyruvate	2.15E+05	1.88E+05	2.82E+05	3.42E+05	1.37E+05	2.69E+05	3.57E+05	2.43E+05	3.31E+05
Lactate	8.94E+05	9.93E+05	8.81E+05	1.84E+06	1.44E+06	1.10E+06	1.47E+06	1.84E+06	1.06E+06
D-Ribose	5.17E+04	4.98E+04	4.93E+04	7.07E+04	4.55E+04	5.54E+04	1.14E+05	4.38E+04	4.77E+04
Citrate	2.17E+06	1.49E+06	1.39E+06	2.86E+06	1.44E+06	2.28E+06	4.40E+06	2.19E+06	2.52E+06
2-Oxoglutarate	9.56E+04	8.81E+04	8.04E+04	1.57E+05	8.86E+04	8.62E+04	1.21E+05	1.41E+05	8.52E+04
Malate	4.99E+05	5.55E+05	1.98E+05	4.30E+05	2.52E+05	8.26E+05	6.21E+05	3.36E+05	4.18E+05
Oxaloacetate	1.37E+06	1.17E+06	1.44E+06	1.65E+06	1.43E+06	1.29E+06	1.30E+06	1.66E+06	1.19E+06
Itaconate	7.36E+05	8.01E+05	3.66E+04	8.99E+02	4.17E+03	7.60E+05	3.02E+05	3.84E+04	0.00E+00
2-Hydroxyglutarate/Citramalate	2.15E+05	1.98E+05	2.52E+05	2.58E+05	2.28E+05	3.47E+05	2.36E+05	2.90E+05	3.33E+05
alpha-D-Ribose 1-phosphate	7.97E+04	4.00E+04	8.59E+04	1.24E+05	5.47E+04	8.44E+04	1.32E+05	1.08E+05	1.68E+05
Ascorbate	1.94E+05	1.62E+05	1.89E+05	4.07E+05	7.57E+04	2.39E+05	4.81E+05	1.21E+05	2.30E+05
N-Acetylneuraminate	1.66E+04	2.37E+03	1.57E+04	1.81E+04	1.39E+04	2.62E+04	1.45E+04	1.08E+04	3.43E+04
alpha-D-Glucosamine 1-phosphate	9.03E+02	4.33E+03	8.72E+03	1.69E+04	1.61E+04	2.26E+03	6.85E+03	1.61E+04	1.77E+04
5-Hydroxyindoleacetate	0.00E+00	7.99E+02	9.92E+02	1.44E+03	9.43E+02	1.79E+03	2.40E+03	4.02E+03	2.45E+03
N-formyl kynurenine	6.39E+04	5.72E+04	7.48E+04	6.01E+04	5.25E+04	6.32E+04	7.84E+04	1.26E+05	1.54E+05
2-Oxoadipate	1.19E+05	1.48E+05	1.59E+05	2.13E+05	5.29E+04	1.78E+05	2.46E+05	8.78E+04	2.00E+05
Glycerol 3-phosphate	3.32E+04	1.53E+04	3.51E+04	5.33E+04	8.56E+03	5.03E+04	5.03E+04	4.23E+04	5.96E+04
Ethanolamine phosphate	6.02E+05	6.31E+05	6.51E+05	8.26E+05	5.15E+05	9.53E+05	7.00E+05	6.90E+05	9.39E+05
2-Methyleneglutarate	1.77E+05	1.89E+05	1.82E+05	2.75E+05	9.44E+04	2.33E+05	3.20E+05	1.36E+05	2.44E+05
6-Lactoyl-5-6-7-8-tetrahydropterin	1.79E+05	2.10E+05	2.19E+05	1.94E+05	1.44E+05	2.35E+05	2.20E+05	3.87E+05	3.69E+05
D-glucono-1,5-lactone	3.88E+05	4.32E+05	4.84E+05	6.17E+05	1.67E+05	4.63E+05	8.32E+05	2.45E+05	5.57E+05
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	KEGG ID	m/z	r.t.
ADP	C00008	426.0205	2.08
Urate	C00366	167.0202	1.18
3',5'-Cyclic IMP	C00943	329.0289	1.24
Phosphate	C00009	96.9677	1.19
Diphosphate	C00013	176.9342	1.11
D-Glucose	C00031	179.0549	1.20
D-Glucose 6-phosphate	C00092	259.0209	1.10
Pyruvate	C00022	87.0069	1.14
Lactate	C01432	89.0225	1.25
D-Ribose	C00121	149.0444	1.15
Citrate	C00158	191.0189	1.15
2-Oxoglutarate	C00026	145.0147	1.23
Malate	C00149	133.0129	1.11
Oxaloacetate	C00036	130.9999	1.18
Itaconate	C00490	129.0177	1.45
2-Hydroxyglutarate/Citramalate	C02630	147.0284	1.09
alpha-D-Ribose 1-phosphate	C00620	229.0107	1.16
Ascorbate	C00072	175.0250	1.22
N-Acetylneuraminate	C00270	308.0974	1.11
alpha-D-Glucosamine 1-phosphate	C06156	258.0366	1.11
5-Hydroxyindoleacetate	C05635	190.0512	2.11
N-formyl kynurenine	C02700	235.0746	1.19
2-Oxoadipate	C00322	159.0285	1.17
Glycerol 3-phosphate	C00093	171.0050	1.12
Ethanolamine phosphate	C00346	140.0100	1.16
2-Methyleneglutarate	C02930	143.0331	1.21
6-Lactoyl-5-6-7-8-tetrahydropterin	C04244	238.0936	1.19
D-glucono-1,5-lactone	C00198	177.0393	1.21
METABOLITES_END
#END